These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34671939)

  • 1. Lipoatrophy, a rare complication of diabetes: a single-center experience.
    Xatzipsalti M; Alvertis H; Kourousi G; Patouni K; Konstantakopoulos S; Delis D; Vazeou A
    Hormones (Athens); 2022 Mar; 21(1):61-69. PubMed ID: 34671939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser treatment for lipoatrophy in children with diabetes type 1.
    Xatzipsalti M; Alvertis H; Vazeou A
    Diabetol Int; 2022 Apr; 13(2):452-455. PubMed ID: 35463860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin-induced lipoatrophy in children].
    Niinikoski H; Näntö-Salonen K; Ruusu P; Kinnala A; Putto-Laurila A; Toppari J; Keskinen P
    Duodecim; 2010; 126(11):1328-32. PubMed ID: 20681357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-induced Lipoatrophy in a Patient on Insulin Analogue Therapy: a Case Report.
    Yanachkova V; Staynova R
    Folia Med (Plovdiv); 2020 Sep; 62(3):597-600. PubMed ID: 33009748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?
    Kordonouri O; Biester T; Weidemann J; Ott H; Remus K; Grothaus J; Pisarek N; Hartmann R; Adolph K; Lange K; Danne T
    Pediatr Diabetes; 2020 Nov; 21(7):1285-1291. PubMed ID: 32738019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
    Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoatrophy in children with type 1 diabetes: an increasing incidence?
    Kordonouri O; Biester T; Schnell K; Hartmann R; Tsioli C; Fath M; Datz N; Danne T
    J Diabetes Sci Technol; 2015 Mar; 9(2):206-8. PubMed ID: 25411060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy.
    Levandoski LA; White NH; Santiago JV
    Diabetes Care; 1982; 5 Suppl 1():6-10. PubMed ID: 6231169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin-induced lipoatrophy--caused by monocomponent insulin?].
    Gyimesi A; Iványi J
    Orv Hetil; 1989 Dec; 130(51):2751-2. PubMed ID: 2689957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin injection lipoatrophy recidivus.
    Rosenbloom AL
    Pediatr Diabetes; 2014 Feb; 15(1):73-4. PubMed ID: 23763651
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes].
    Dziura M; Wasikowa R
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):61-3. PubMed ID: 18577350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoatrophy is associated with an increased risk of Hashimoto's thyroiditis and coeliac disease in female patients with type 1 diabetes.
    Salgin B; Meissner T; Beyer P; Haberland H; Borkenstein M; Fussenegger J; Brand U; Hauffa BP; Hungele A; Holl RW
    Horm Res Paediatr; 2013; 79(6):368-72. PubMed ID: 23796529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.